{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:12:15Z","timestamp":1771002735010,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.beem.2017.03.001","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T02:01:02Z","timestamp":1489024862000},"page":"13-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Management of GH treatment in adult GH deficiency"],"prefix":"10.1016","volume":"31","author":[{"given":"Valentina","family":"Gasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Lanfranco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezio","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Grottoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2017.03.001_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults","volume":"16","author":"de Boer","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.03.001_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.03.001_bib3","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients \u2013 2009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2017.03.001_bib6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"J\u00f8rgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2017.03.001_bib7","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.03.001_bib8","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem.84.1.5408","article-title":"Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study","volume":"84","author":"Toogood","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib10","first-page":"550","article-title":"Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women","volume":"82","author":"Burman","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib11","first-page":"6","article-title":"Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency","volume":"65","author":"Yuen","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2017.03.001_bib12","doi-asserted-by":"crossref","first-page":"E1191","DOI":"10.1152\/ajpendo.2001.281.6.E1191","article-title":"Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women","volume":"281","author":"Wolthers","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11154-008-9089-x","article-title":"Growth hormone receptor modulators","volume":"10","author":"Birzniece","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2017.03.001_bib14","first-page":"3956","article-title":"Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults","volume":"84","author":"Cook","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib15","first-page":"464","article-title":"A\u00a0switch from oral (2 mg\/day) to transdermal (50 microg\/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency","volume":"85","author":"Janssen","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/eje.1.01936","article-title":"An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency","volume":"153","author":"Chihara","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2265.2002.01508.x","article-title":"Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome","volume":"56","author":"Murray","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1530\/EJE-13-0005","article-title":"Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak","volume":"168","author":"Feldt-Rasmussen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2265.2000.00971.x","article-title":"Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency","volume":"52","author":"Murray","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib20","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1210\/jc.2005-0185","volume":"90","author":"Verhelst","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2265.2004.02018.x","article-title":"Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease","volume":"60","author":"Johannsson","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib22","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/jc.2007-2673","article-title":"Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly","volume":"93","author":"Norrman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11102-009-0186-y","article-title":"Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly","volume":"12","author":"van der Klaauw","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.03.001_bib24","first-page":"1371","article-title":"Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers","volume":"81","author":"de Boer","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib25","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1210\/jc.2003-032082","article-title":"Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing","volume":"89","author":"Hoffman","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety","volume":"50","author":"Abs","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib27","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jcem.83.11.5223","article-title":"Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults","volume":"83","author":"Drake","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults","volume":"47","author":"Johannsson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib29","first-page":"129","article-title":"A\u00a0low starting dose of genotropin in growth hormone-deficient adults","volume":"82","author":"Janssen","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2265.1995.tb01908.x","article-title":"Which adults develop side-effects of growth hormone replacement?","volume":"43","author":"Holmes","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib31","first-page":"2877","article-title":"Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults","volume":"82","author":"Johannsson","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jcem-60-3-513","article-title":"The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals","volume":"60","author":"Zadik","year":"1985","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib33","first-page":"61","article-title":"Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency","volume":"31","author":"Scaroni","year":"2008","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.03.001_bib34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1530\/eje.1.02017","article-title":"Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults","volume":"153","author":"Mukherjee","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ajhb.20055","article-title":"Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: a randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone","volume":"16","author":"Bell","year":"2004","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.beem.2017.03.001_bib36","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1161\/01.ATV.15.12.2142","article-title":"Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes","volume":"15","author":"Johannsson","year":"1995","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"10.1016\/j.beem.2017.03.001_bib37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1359\/jbmr.2002.17.6.1081","article-title":"The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial","volume":"17","author":"Bex","year":"2002","journal-title":"J\u00a0Bone Mineral Res"},{"key":"10.1016\/j.beem.2017.03.001_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2265.2001.01246.x","article-title":"The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study","volume":"54","author":"Drake","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib39","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.96.12.7088","article-title":"Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice","volume":"96","author":"Sj\u00f6gren","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2017.03.001_bib40","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group","volume":"82","author":"Attanasio","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1530\/EJE-09-0973","article-title":"Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults","volume":"162","author":"Barbosa","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF03343754","article-title":"Intersubject responsiveness of high-affinity growth hormone (GH)-binding protein (GHBP) to long-term GH replacement therapy","volume":"23","author":"De Vries","year":"2000","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.03.001_bib43","first-page":"58","article-title":"Gender difference in growth hormone response in adults","volume":"22","author":"Johansson","year":"1999","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.03.001_bib44","first-page":"2865","article-title":"Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency","volume":"81","author":"Johannsson","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.1999.00838.x","article-title":"Influences on quality of life in GH deficient adults and their effect on response to treatment","volume":"51","author":"Murray","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/edrv-12-3-189","article-title":"Human growth hormone replacement therapy: pharmacological and clinical aspects","volume":"12","author":"J\u00f8rgensen","year":"1991","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.03.001_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2265.1994.tb03934.x","article-title":"Pharmacokinetics and metabolic effects of growth hormone injected subcutaneously in growth hormone deficient patients: thigh versus abdomen","volume":"40","author":"Laursen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0773.1991.tb01252.x","article-title":"Influence of concentration and injection volume on the bioavailability of subcutaneous growth hormone: comparison of administration by ordinary syringe and by injection pen","volume":"68","author":"Blok","year":"1991","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.beem.2017.03.001_bib49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2265.1994.tb02554.x","article-title":"Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults","volume":"41","author":"Laursen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib50","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1210\/endo-123-2-1053","article-title":"Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C\/insulin-like growth factor I and liver GH receptors in hypophysectomized rats","volume":"123","author":"Maiter","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.03.001_bib51","first-page":"1222","article-title":"Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults","volume":"86","author":"Laursen","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib52","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1210\/jcem.85.10.6881","article-title":"Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections","volume":"85","author":"Amato","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jcem-70-1-207","article-title":"Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites","volume":"70","author":"J\u00f8rgensen","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib54","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jcem.87.4.8394","article-title":"GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis","volume":"87","author":"Johannsson","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib55","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1210\/jcem.87.6.8542","article-title":"Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults","volume":"87","author":"Ezzat","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM199308263290917","article-title":"Growth hormone, insulin-like growth factor I, and benign intracranial hypertension","volume":"329","author":"Malozowski","year":"1993","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.03.001_bib57","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-08-0436","article-title":"Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency","volume":"160","author":"Conway","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib58","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jcem.87.5.8479","article-title":"Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory?","volume":"87","author":"Porretti","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/ghir.2001.0263","article-title":"Growth hormone replacement therapy for adults: into the new millennium","volume":"12","author":"Simpson","year":"2002","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.beem.2017.03.001_bib60","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2011-0448","article-title":"Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis","volume":"96","author":"Attanasio","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2010.10.005","article-title":"The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database","volume":"21","author":"Spielhagen","year":"2011","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.beem.2017.03.001_bib62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-11-0286","article-title":"Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study","volume":"165","author":"Child","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib63","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1210\/jc.2012-2684","article-title":"Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients","volume":"98","author":"Hartman","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib64","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib65","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10072-015-2269-z","article-title":"Growth hormone therapy and risk of recurrence\/progression in intracranial tumors: a meta-analysis","volume":"36","author":"Shen","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.beem.2017.03.001_bib66","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-14-1123","article-title":"Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study","volume":"172","author":"Child","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.001_bib67","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2015-1764","article-title":"Tumor recurrence or regrowth in adults with nonfunctioning pituitary adenomas using GH replacement therapy","volume":"100","author":"van Varsseveld","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2265.2005.02404.x","article-title":"Does growth hormone cause cancer?","volume":"64","author":"Jenkins","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI20660","article-title":"The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity","volume":"113","author":"Clemmons","year":"2004","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.beem.2017.03.001_bib70","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment","volume":"355","author":"Cutfield","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2017.03.001_bib71","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","article-title":"Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults","volume":"87","author":"Svensson","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib72","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2265.2002.01601.x","article-title":"The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults","volume":"57","author":"Yuen","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib73","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Metaanalysis of blinded, randomized, placebo-controlled trials. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2017.03.001_bib75","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/jc.2007-2810","article-title":"Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency","volume":"93","author":"Colao","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2265.2009.03612.x","article-title":"Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects","volume":"72","author":"Woodmansee","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.03.001_bib77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/jc.2011-1995","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study","volume":"97","author":"Carel","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib78","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1210\/jc.2011-2882","article-title":"Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study","volume":"97","author":"S\u00e4vendahl","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.001_bib79","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1210\/jc.2013-2415","article-title":"Update in mortality in GH-treated patients","volume":"98","author":"Erfurth","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:52:15Z","timestamp":1761497535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X17300076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1521690X17300076"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2017.03.001","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of GH treatment in adult GH deficiency","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2017.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}